GO:2000872 positive regulation of progesterone secretion: Steroidogenic Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000872 describes any biological process that activates or increases the frequency, rate, or extent of progesterone secretion.
• Progesterone secretion is primarily driven by the corpus luteum and placenta, and is tightly controlled by transcriptional regulators such as SP1, CREB, and NR5A1.
• Gonadotropins (LH/hCG) and local factors like prostaglandins and estradiol modulate progesterone output in a cell-type-specific manner.
• Dysregulation of progesterone secretion is linked to luteal phase defects, endometriosis, and breast cancer progression.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect causal roles of candidate genes in progesterone regulation.
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate research on GO:2000872.
Description
Progesterone is a steroid hormone essential for female reproductive physiology, including menstrual cycle regulation, implantation, and maintenance of pregnancy. The process of positive regulation of progesterone secretion (GO:2000872) encompasses all molecular events that enhance the synthesis and release of progesterone from steroidogenic cells, particularly luteal and placental cells. Understanding this process is critical because insufficient or excessive progesterone secretion underlies multiple reproductive disorders and cancers. This article integrates authoritative GO annotation with published literature to provide a research-grade overview of the mechanisms, key genes, and experimental models relevant to GO:2000872.
positive regulation of progesterone secretion At A Glance
| GO ID | GO:2000872 |
|---|---|
| GO term | positive regulation of progesterone secretion |
| Ontology | biological_process |
| Synonym | none |
| Major function | Upregulation of progesterone secretion from steroidogenic tissues |
| Related processes | Steroid biosynthesis, luteal function, gonadotropin signaling |
| Key regulators | LH/hCG, SP1, CREB, NR5A1, prostaglandins |
| Disease relevance | Luteal phase defect, endometriosis, breast cancer |
What Is GO:2000872?
GO:2000872, positive regulation of progesterone secretion, is defined as any process that activates or increases the frequency, rate, or extent of progesterone secretion. This biological process includes signaling cascades, transcriptional activation of steroidogenic enzymes, and cellular changes that ultimately elevate progesterone release from endocrine cells.
Why Is positive regulation of progesterone secretion Important in Cell Biology?
Positive regulation of progesterone secretion is fundamental for reproductive success and hormonal homeostasis. Aberrant upregulation can contribute to progesterone-dependent pathologies such as endometriosis and breast cancer, while failure to upregulate appropriately leads to luteal insufficiency and pregnancy loss. Therefore, understanding the molecular drivers of this process offers therapeutic targets and biomarkers for reproductive and oncologic diseases.
• Essential for menstrual cycle regulation and maintenance of early pregnancy.
• Key to corpus luteum function and luteal phase support.
• Involved in endometrial receptivity and implantation.
• Dysregulated in endometriosis and progesterone resistance.
• Contributes to breast cancer cell proliferation via progesterone receptor signaling.
• Target for contraceptive and hormone replacement therapies.
• Regulated by gonadotropins and local paracrine factors.
• Provides a model for studying steroidogenic gene transcription.
• Relevant to ovarian and placental physiology.
• Offers opportunities for CRISPR-based functional genomics.
What Happens During positive regulation of progesterone secretion?
Initiation by Gonadotropins and Signaling Cascades
In simple terms: The process starts when hormones like LH bind to receptors on steroidogenic cells.
Luteinizing hormone (LH) and human chorionic gonadotropin (hCG) bind to their receptors on luteal cells, activating adenylyl cyclase and increasing cAMP levels. This triggers protein kinase A (PKA) signaling, which phosphorylates transcription factors such as CREB, leading to enhanced expression of steroidogenic acute regulatory protein (STAR) and cytochrome P450 side-chain cleavage enzyme (CYP11A1).
Transcriptional Activation of Steroidogenic Genes
In simple terms: Specific transcription factors turn on genes needed to make progesterone.
Key transcription factors including SP1, CREB, and NR5A1 (SF-1) bind to promoters of genes encoding steroidogenic enzymes such as CYP11A1, HSD3B2, and STAR, increasing their transcription. This transcriptional upregulation is a hallmark of positive regulation of progesterone secretion and is modulated by coactivators and epigenetic changes.
Cholesterol Transport and Enzymatic Conversion
In simple terms: Cholesterol is moved into mitochondria and converted to progesterone.
STAR protein facilitates cholesterol transfer from the outer to inner mitochondrial membrane, where CYP11A1 converts cholesterol to pregnenolone. Pregnenolone is then converted to progesterone by 3β-hydroxysteroid dehydrogenase (HSD3B2) in the smooth endoplasmic reticulum. Increased expression or activity of these enzymes directly enhances progesterone output.
Local Amplification by Prostaglandins and Estradiol
In simple terms: Other local signals can boost progesterone production.
Prostaglandin F2alpha (PGF2alpha) and estradiol modulate progesterone secretion in a context-dependent manner. In the corpus luteum, PGF2alpha can either stimulate or inhibit progesterone depending on the species and stage, while estradiol can enhance progesterone synthesis in the brain and other tissues. These local factors fine-tune the positive regulation of progesterone secretion.
Feedback and Feedforward Loops
In simple terms: The process is controlled by feedback loops to maintain balance.
Progesterone itself can exert negative feedback on GnRH secretion, but positive regulation of progesterone secretion involves feedforward mechanisms such as the GREB1-steroid receptor loop in endometrium. This loop amplifies progesterone action and secretion in target tissues, contributing to differential responses in health and disease.
Key Genes Involved in GO:2000872 positive regulation of progesterone secretion
The following genes are central to the positive regulation of progesterone secretion, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STAR | Cholesterol transport into mitochondria | Rate-limiting step in progesterone synthesis |
| CYP11A1 | Conversion of cholesterol to pregnenolone | Key enzyme for progesterone production |
| HSD3B2 | Conversion of pregnenolone to progesterone | Directly produces progesterone |
| NR5A1 | Transcription factor activating steroidogenic genes | Master regulator of steroidogenesis |
| SP1 | Transcription factor binding GC-rich promoters | Regulates CYP11A1 and HSD3B2 |
| CREB1 | cAMP-responsive transcription factor | Mediates gonadotropin signaling |
| LHCGR | LH/hCG receptor | Initiates signaling cascade |
| GREB1 | Steroid receptor coactivator | Feedforward loop in endometrium |
| PGR | Progesterone receptor | Mediates progesterone action |
| SGK1 | Serum/glucocorticoid-regulated kinase | Upregulated by progesterone in breast cancer |
| AP-1 | Transcription factor complex | Downstream of SGK1-NDRG1 axis |
| NDRG1 | Differentiation-related gene | Effector in progesterone signaling |
| PTGS2 | Prostaglandin-endoperoxide synthase 2 | Produces prostaglandins affecting secretion |
| ESR1 | Estrogen receptor alpha | Modulates progesterone synthesis |
| ESR2 | Estrogen receptor beta | Modulates progesterone synthesis |
| PKA | Protein kinase A | Phosphorylates CREB and other targets |
| PRKACA | Catalytic subunit of PKA | Mediates cAMP effects |
How Is positive regulation of progesterone secretion Regulated?
Positive regulation of progesterone secretion is controlled by a network of endocrine, paracrine, and autocrine signals. Gonadotropins (LH/hCG) activate cAMP/PKA signaling, leading to CREB phosphorylation and transcriptional activation of steroidogenic genes. Local factors such as prostaglandins and estradiol modulate this process. Additionally, feedforward loops involving GREB1 and steroid receptors amplify progesterone action in target tissues. Negative feedback by progesterone on GnRH secretion helps maintain homeostasis.
positive regulation of progesterone secretion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GREB1 | Endometriosis | Knockout in endometrial cells |
| SGK1 | Breast cancer | Overexpression in breast cancer cell lines |
| STAR | Luteal phase defect | Knockout in luteal cells |
| CYP11A1 | Steroidogenic disorders | Point mutation knock-in |
| PGR | Progesterone resistance | Knock-in of mutant receptor |
Endometriosis and Progesterone Resistance
Endometriosis is characterized by progesterone resistance and aberrant GREB1-steroid receptor signaling, which disrupts normal progesterone secretion and action. Dysregulation of positive regulation of progesterone secretion may contribute to lesion survival and pain.
Breast Cancer
Progesterone can promote breast cancer cell proliferation through SGK1 upregulation and activation of the AP-1-NDRG1 axis, highlighting the importance of understanding positive regulation of progesterone secretion in oncology.
Luteal Phase Defect and Infertility
Insufficient progesterone secretion due to impaired positive regulation can lead to luteal phase defect, implantation failure, and early pregnancy loss. Research into the molecular drivers of this process is essential for developing therapies.
From positive regulation of progesterone secretion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate progesterone secretion? | CRISPR knockout in steroidogenic cell lines |
| Does a specific mutation affect enzyme activity? | Point mutation knock-in |
| Can a tagged protein track localization? | Tagged knock-in |
| Does overexpression enhance secretion? | Overexpression cell model |
| Which genes are essential for luteal function? | CRISPR library screening |
| What are the transcriptomic changes? | RNA-seq after knockout |
How to Study the positive regulation of progesterone secretion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome changes | Identify differentially expressed genes |
| Proteomics | Protein abundance and modifications | Quantify steroidogenic enzymes |
| ELISA | Progesterone concentration | Measure secretion in media |
| LC-MS/MS | Steroid profiling | Quantify multiple steroids |
| CRISPR screening | Gene essentiality | Identify regulators of secretion |
| ChIP-seq | Transcription factor binding | Map promoter occupancy |
| Live-cell imaging | Protein localization | Track cholesterol transport |
Transcriptomic Analysis
RNA-seq can identify global changes in gene expression following CRISPR knockout or overexpression of candidate regulators of progesterone secretion.
Proteomic and Phosphoproteomic Profiling
Mass spectrometry-based proteomics can quantify steroidogenic enzymes and signaling intermediates, revealing post-translational regulation.
Hormone Secretion Assays
ELISA or LC-MS/MS can measure progesterone levels in culture media or serum, providing direct functional readouts.
Imaging and Localization Studies
Fluorescence microscopy of tagged proteins can track cholesterol transport and enzyme localization in live cells.
How CRISPR Can Be Used to Study GO:2000872 positive regulation of progesterone secretion
Knockout
CRISPR knockout of candidate genes such as STAR, CYP11A1, or GREB1 in steroidogenic cell lines can determine their necessity for progesterone secretion.
Point Mutation
Introducing specific point mutations in genes like HSD3B2 or PGR can model clinical variants and assess their impact on enzyme activity or receptor function.
Knock-in
Knock-in of tagged versions of proteins (e.g., GFP-STAR) allows real-time tracking of localization and dynamics during progesterone synthesis.
Overexpression
Overexpression of transcription factors such as NR5A1 or SP1 can test sufficiency for enhancing progesterone secretion.
How EDITGENE Supports positive regulation of progesterone secretion Research
Researchers studying positive regulation of progesterone secretion-related genes often need to determine whether a candidate gene is causally involved in the process. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of progesterone secretion research.
Frequently Asked Questions About positive regulation of progesterone secretion
What is GO:2000872?
GO:2000872 is the Gene Ontology term for positive regulation of progesterone secretion, describing any process that increases the frequency, rate, or extent of progesterone release.
What genes are involved in positive regulation of progesterone secretion?
Key genes include STAR, CYP11A1, HSD3B2, NR5A1, SP1, CREB1, LHCGR, GREB1, and PGR, among others.
How is progesterone secretion regulated?
It is regulated by gonadotropins via cAMP/PKA signaling, transcriptional activation of steroidogenic genes, and local factors like prostaglandins and estradiol.
What diseases are associated with abnormal progesterone secretion?
Luteal phase defect, endometriosis, infertility, and breast cancer are linked to dysregulated progesterone secretion.
What is the role of STAR in progesterone secretion?
STAR transports cholesterol into mitochondria, the rate-limiting step for progesterone synthesis.
How can CRISPR be used to study progesterone secretion?
CRISPR knockout, knock-in, and overexpression can test the causal role of specific genes in progesterone production.
What cell models are used to study progesterone secretion?
Common models include luteal cells, granulosa cells, placental cells, and steroidogenic cell lines like MA-10 and KGN.
What is the GREB1-steroid receptor feedforward loop?
It is a mechanism where GREB1 amplifies progesterone receptor signaling, affecting endometrial function and endometriosis.
How does progesterone affect breast cancer?
Progesterone can upregulate SGK1, activating AP-1 and NDRG1 to promote proliferation in breast cancer cells.
What methods measure progesterone secretion?
ELISA and LC-MS/MS are commonly used to quantify progesterone in culture media or serum.
Conclusion
Positive regulation of progesterone secretion (GO:2000872) is a critical biological process with profound implications for reproductive health and disease. Understanding its molecular mechanisms, key genes, and regulatory networks provides a foundation for developing targeted therapies. EDITGENE's CRISPR services empower researchers to dissect this process with precision and scale.
References
- 1. Herbison AE. 2020. A simple model of estrous cycle negative and positive feedback regulation of GnRH secretion.. Front Neuroendocrinol 57:100837 PMID: 32240664
- 2. Sitruk-Ware R. 2018. Non-clinical studies of progesterone.. Climacteric 21(4):315-320 PMID: 29790373
- 3. Mizutani T et al.. 2015. Transcriptional regulation of genes related to progesterone production.. Endocr J 62(9):757-63 PMID: 26135521
- 4. Micevych P et al.. 2008. Estradiol regulation of progesterone synthesis in the brain.. Mol Cell Endocrinol 290(1-2):44-50 PMID: 18572304
- 5. Diaz FJ et al.. 2002. Regulation of progesterone and prostaglandin F2alpha production in the CL.. Mol Cell Endocrinol 191(1):65-80 PMID: 12044920
- 6. Chadchan SB et al.. 2024. A GREB1-steroid receptor feedforward mechanism governs differential GREB1 action in endometrial function and endometriosis.. Nat Commun 15(1):1947 PMID: 38431630
- 7. Devoto L et al.. 2002. Molecular regulation of progesterone secretion by the human corpus luteum throughout the menstrual cycle.. J Reprod Immunol 55(1-2):11-20 PMID: 12062818
- 8. Godbole M et al.. 2018. Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1-NDRG1 axis in both PR-positive and -negative breast cancer cells.. J Biol Chem 293(50):19263-19276 PMID: 30337371
